AUPH — Aurinia Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
- $1.03bn
- $778.03m
- $175.51m
- 71
- 28
- 68
- 55
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -88.4 | -103 | -181 | -108 | -78 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 21.6 | 26.9 | 42.1 | 32.8 | 38.5 |
Other Non-Cash Items | |||||
Changes in Working Capital | 2.03 | 4.52 | -21.6 | -6.82 | -5.61 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -63.6 | -69.9 | -158 | -79.5 | -33.5 |
Capital Expenditures | -0.101 | -7.34 | -1.5 | -0.292 | -0.718 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 7.88 | -151 | -102 | -60.3 | -5.99 |
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 7.78 | -158 | -104 | -60.6 | -6.71 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 244 | 194 | 221 | 2.43 | -5.13 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 188 | -33.7 | -40.5 | -138 | -45.3 |